An Open-Label, Dose Escalation, Efficacy, and Safety Study of CLR 131 in Children, Adolescents, and Young Adults with Select Solid Tumors, Lymphoma, and Malignant Brain Tumors (CLOVER-2)
Clinical Trial Grant
Administered By
Pediatrics, Hematology-Oncology
Awarded By
Cellectar Biosciences, Inc.
Start Date
December 29, 2021
End Date
December 31, 2023
Administered By
Pediatrics, Hematology-Oncology
Awarded By
Cellectar Biosciences, Inc.
Start Date
December 29, 2021
End Date
December 31, 2023